The European Federation of Pharmaceutical Industries and Associations ( EFPIA ) has provided further evidence of the potential health risks posed by the upcoming relocation of the European Medicines Agency (EMA).
In a statement, EFPIA says its latest survey underlines the scale and iOriginal Article